NCT05977127 Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly Status TERMINATED Phase PHASE2
NCT05858450 This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times. Status COMPLETED Phase N/A
NCT05781191 Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine Status COMPLETED Phase N/A
NCT05396573 A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 Status UNKNOWN Phase PHASE1
NCT05394012 A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 Status UNKNOWN Phase PHASE1
NCT05378191 Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose Status UNKNOWN Phase PHASE2
NCT05329220 ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 Status COMPLETED Phase PHASE3
NCT05329051 A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years Status UNKNOWN Phase PHASE2
NCT05323461 A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines Status UNKNOWN Phase PHASE3
NCT05239975 A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine Status WITHDRAWN Phase PHASE2
NCT05239806 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05238454 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05238441 A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine Status UNKNOWN Phase PHASE2
NCT05075538 COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 Status TERMINATED Phase PHASE4
NCT04907331 Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 Status UNKNOWN Phase PHASE2
NCT04569383 Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19 Status COMPLETED Phase PHASE1